Cancer drug company Atreca terminated a nearly 100K SF lease in a San Carlos, California, property owned by Alexandria Real Estate, according to a press release and a filing with the Securities and Exchange Commission […]
It’s been 10 years since former Genentech CEO Art Levinson teamed with Google to launch Calico. Now new aging-focused companies and investors are boldly claiming they not only want to slow the aging process but […]
Second Injunction Issued Against CosMx PLEASANTON, Calif., Sept. 19, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court (“UPC”) issued […]
Seeing the successes of other covalent medicines companies, a group of blue-chip investors is lining up to take the next shot on goal. RA Capital, typically known for its late-stage and crossover investments, is getting […]
The company, whose stock neared $49 within days of its December 2020 IPO, closed Monday at $1.70 per share. Click here to view original post Click here to view San Francisco Biotech Networks Trending News
QUAKERTOWN, Pa., Sept. 18, 2023 /PRNewswire/ — Leading innovator of dental imaging technologies, DEXIS, announces the launch of the next-generation OP 3D. Built on OP 3D technology, the OP 3D LX introduces expanded 3D diagnostic […]
TARRYTOWN, NY — For over three decades, Regeneron has been synonymous with one thing in the drug industry: antibodies. Blockbusters like Dupixent, Eylea, and Covid-19 antibodies have transformed what started as a scrappy startup into […]
BERKELEY, Calif., Sept. 18, 2023 /PRNewswire/ — ResVita Bio, a synthetic biology startup, announces that it has been awarded a $250,000 Phase 1 Small Business Innovation Research (SBIR) grant by the National Institute of Allergy […]
Biotech Networks’ 2023/2024 US tour is back in San Francisco October 25th 2023! Our Bay Area events started just before the COVID-19 pandemic in October 2019, and we’re happy to be back in the same […]
Strengthen cellular analysis with cost-efficient multiomic readouts and streamlined workflows PLEASANTON, Calif., Sept. 14, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability […]
© 2023 Biotech Networks, LLC
